HLA associations in chronic vision threatening Uveitis

Seminars in Ophthalmology

Volumn 28, Issue 5-6, 2013, Pages 333-336

  Sarup, Vimal ^a,b,c   Foster, C Stephen ^a,b,c  

^a MASSACHUSETTS EYE RESEARCH AND SURGERY INSTITUTION   (United States)

^b Massachusetts Eye Research and Surgery Institute   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Blinding; Human leukocyte antigen; Immunology; Inflammation; Ocular

Indexed keywords

EPITOPE; HLA ANTIGEN; HLA B ANTIGEN; HLA B27 ANTIGEN; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; HLA DR15 ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADAMANTAIDES BEHCET DISEASE; ANKYLOSING SPONDYLITIS; ANTIGEN EXPRESSION; AUTOIMMUNE DISEASE; BLINDNESS; CD8+ T LYMPHOCYTE; COMPLEMENT DEPENDENT CYTOTOXICITY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ENTERITIS; ETHNIC DIFFERENCE; GENETIC SUSCEPTIBILITY; GENOTYPE PHENOTYPE CORRELATION; GEOGRAPHIC DISTRIBUTION; HLA TYPING; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INFLAMMATORY DISEASE; INTERMEDIATE UVEITIS; INTERSTITIAL NEPHRITIS; IRIDOCYCLITIS; JUVENILE RHEUMATOID ARTHRITIS; LABORATORY TEST; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; PHENOTYPE; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; REITER SYNDROME; RETINA DISEASE; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TUBULOINTERSTITIAL NEPHRITIS AND UVEITIS; UVEITIS; VITILIGINOUS CHORIORETINITIS;

ANIMALS; CHRONIC DISEASE; HLA ANTIGENS; HUMANS; UVEITIS; VISION DISORDERS;

EID: 84886409006     PISSN: 08820538     EISSN: 17445205     Source Type: Journal    
DOI: 10.3109/08820538.2013.825282     Document Type: Review

References (34)

1. Krieglstein G, Weinreb R, Pleyer U, Foster CS. Uveitis and Immunological Disorders. Berlin: Spinger/Verlag, 2007. pp 103-106.
2. Abi-Hanna D, Wakefield D, Watkins S. HLA antigens in ocular tissues. I. Transplantation 1988;45(3):610-613.
3. Zamecki K J, Jabs D. A HLA Typing in uveitis: use and misuse. Am J Ophthalmol 2010;149:189-193.
4. Nussenblatt RB, Mittal KK, Ryan S, et al. Birdshot retinochoroidopathy associated with HLA-A29 antigen and immune responsiveness to retinal S-antigen. Am J Ophthalmol 1982;94(2):147-158.
5. Feltkamp T E. HLA and uveitis. Int Ophthalmol 1990;14(5-6):327-333.
6. Foster CS, Vitale A. Diagnosis & Treatment of Uveitis. New Delhi: Jaypee Brothers Medical Publishers, 2013.
7. Ohno S, Ohguchi M, Hirose S, et al. Close association of HLA-Bw51 with Behçet's disease. Arch Ophthalmol 1982; 100:1455-1458.
8. Mishima S, Masuda K, Izawa Y, et al. Behçet's disease in Japan: ophthalmologic aspects. Trans Am Ophthalmol Soc 1979;76:225-279.
9. Raizman MB, Foster CS. Plasma exchange in the therapy of Behçet's disease. Graefes Arch Clin Exp Ophthalmol 1989;227: 360-363.
10. Yazici H, Chamberlain MA, Schieuder I, et al. HLA antigens in Behçet's disease: a reappraisal by a comparative study of Turkish and British patients. Ann Rheum Dis 1980;39:344-348.
11. Zouboulis CC, Kotter I, Djawari D, et al. Epidemiological features of Adamntiades-Behçet's disease in Germany and in Europe. Yonsei Med J 1997;38:411-422.
12. Zervas J, Vayopoulos G, Sakellaropoulos N, Kaklamanis P, Fessas P. HLA antigens and Adamantiades-Behçet's disease (A-BD) in Greeks. Clin Exp Rheumatol 1988;6: 277-280.
13. Ohno S, Char DH, Kimura SJ, et al. Studies on HLA antigens in American patients with Behçet's disease. Jpn J Ophthalmol 1978;22:58-61.
14. O'Duffy JD, Taswell HF, Elveback LR. HL-A antigens in Behçet's disease. J Rheumatol 1976;3:1-3.
15. Mizuki N, Inokoko H, Ando H, et al. Behçet's disease associated with one of the HLA-B51 subantigens, HLA-B*5101. Am J Ophthalmol 1993;116:406-409.
16. Koumantaki Y, Stavropoulos K, Spyropoulou M, et al. HLA-B*5101 in Greek patients with Behçet's disease. Human Immunol 1998;59:250-255.
17. Lehner T, Barnes CG. Criteria for diagnosis and classification of Behçet's syndrome. In: Behçet's Syndrome: Clinical and Immunological Features (Lehner T, Barnes CG, Eds.), Proceedings of a Conference Sponsored by Royal Society of Medicine, February 1979; London: Academic Press, 1979; 1-9.
18. Shindo Y, Inoko H, Yamamoto T, et al. HLA-DRBI typing of Vogt-Koyanagi-Harada disease by PCR-RFLP and the strong association with DRBI 0405. Br J Ophthalmol 1994; 78:223-226.
19. Weisz J, Holland G, Roer L, et al. HLA associations in Hispanic patients with Vogt-Koyanagi-Harada syndrome. Invest Ophthalmol Vis Sci 1994;35(suppl):2097.
20. Zhao M, Jiang Y, Abrahams I. Association of HLA antigens with Vogt-Koyanagi-Harada syndrome in a Han Chinese population. Arch Ophthalmol 1991;109:368-370.
21. Davis J, Mittal, KK, Freidlin, V. HLA association and ancestry in VKH and sympathetic ophthalmia. Ophthalmology 1990;97:1137-1142.
22. Martin T, Weber M, Schmitt C, et al. Association of intermediate uveitis with HLA-A28: definition of a new systemic syndrome? Graefe's Arch Clin Exp Ophthalmol 1995; 233:269-274.
23. Tang WM, Pulido JS, Eckels DD, et al. The association of HLADR15 and intermediate uveitis. Am J Ophthalmol 1997; 123:70-75.
24. Raja SC, Jabs DA, Dunn JP, et al. Pars planitis: clinical features and class II HLA associations. Ophthalmology 1999; 106:594-599.
25. Oruc S, Duffy BF, Mohanakumar T, et al. The association of HLA class II with pars planitis. Am J Ophthalmol 2001;131: 657-659.
26. Mantrana-Bermejo ME, Rueda-Rueda T, Bernabeu-Wittel J, et al. Clinical and epidemiological features and HLA association in patients with pars planitis. Med Clin (Barc) 2010;135:205-208.
27. Greiner KH, Wilson DW, Thomson J, et al. Genetic polymorphism of HLA DR in a Scottish population of patients with pars planitis. Eur J Ophthalmol 2003;13:433-438.
28. Chang JH, McCluskey PJ, Wakefield D. Acute anterior uveitis and HLA-B27. Surv Ophthalmol 2005; 50:364-368.
29. Brewerton DA, Caffrey M, Hart FD, et al. Ankylosing spondylitis and HLA-B27. Lancet 1973;1:904-907.
30. Rosenbaum JT. Characterization of uveitis associated with spondyloarthritis. J Rheumatol 1989;16:792-796.
31. Tay Kearney ML, Schwam BL, Lowder C, et al. Clinical features and associated systemic disease of HLA-B27 uveitis. Am J Ophthalmol 1996;121:47-56.
32. Linssen A, Meenken C. Outcomes of HLA-B27-positive and HLAB27-negative acute anterior uveitis. Am J Ophthalmol 1995;120:351-361.
33. Levinson RD, Park MS, Rikkers SM, et al. Strong associations between specific HLA-DQ and HLA-DR alleles and the tubulointerstitial nephritis and uveitis syndrome. Invest Ophthalmol Vis Sci 2003;44:653-657
34. American Academy of Ophthalmology. BCSC series section 9. Intraocular Inflammation and Uveitis. Singapore: Lifelong Education for the Ophthalmologist. 2009.